The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens

Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal th...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 18; no. 1; pp. 1205 - 6
Main Authors Mai, Zhipeng, Zhou, Zhien, Yan, Weigang, Xiao, Yu, Zhou, Yi, Liang, Zhiyong, Ji, Zhigang, Li, Hanzhong
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 04.12.2018
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
AbstractList Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor. Keywords: Spatial distribution, Biopsy, Radical prostatectomy, Apex
Abstract Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9–1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Methods Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. Results The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9–1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. Conclusion The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens. Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared. The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens. The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens.BACKGROUNDProstate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy specimens is the most reliable method for verifying the accuracy of template-guided transperineal prostate biopsy. The study aimed to reveal the spatial distribution of prostate cancer in template-guided transperineal saturation biopsy and radical prostatectomy specimens.Between December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared.METHODSBetween December 2012 to December 2016, 171 patients were diagnosed with prostate cancer via template-guided transperineal prostate biopsy and subsequently underwent laparoscopic radical prostatectomy. The spatial distributions of prostate cancer were analyzed and the consistency of the tumor distribution between biopsy and radical prostatectomy specimens were compared.The positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens.RESULTSThe positive rate of biopsy in the apex region was significantly higher than that of the other biopsy regions (43% vs 28%, P < 0.01). In radical prostatectomy specimens, the positive rate was highest at the region 0.9-1.3 cm above the apex, and it had a tendency to decrease towards the base. There was a significant difference in the positive rate between the cephalic and caudal half of the prostate (68% vs 99%, P < 0.01). There were no significant differences between the anterior and posterior zones for either biopsy or radical prostatectomy specimens.The tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.CONCLUSIONThe tumor spatial distribution generated by template-guided transperineal prostate biopsy was consistent with that of radical prostatectomy specimens in general. The positive rate was consistent between anterior and posterior zones. The caudal half of the prostate, especially the vicinity of the apex, was the frequently occurred site of the tumor.
ArticleNumber 1205
Audience Academic
Author Li, Hanzhong
Liang, Zhiyong
Mai, Zhipeng
Xiao, Yu
Yan, Weigang
Zhou, Zhien
Zhou, Yi
Ji, Zhigang
Author_xml – sequence: 1
  givenname: Zhipeng
  surname: Mai
  fullname: Mai, Zhipeng
– sequence: 2
  givenname: Zhien
  surname: Zhou
  fullname: Zhou, Zhien
– sequence: 3
  givenname: Weigang
  surname: Yan
  fullname: Yan, Weigang
– sequence: 4
  givenname: Yu
  surname: Xiao
  fullname: Xiao, Yu
– sequence: 5
  givenname: Yi
  surname: Zhou
  fullname: Zhou, Yi
– sequence: 6
  givenname: Zhiyong
  surname: Liang
  fullname: Liang, Zhiyong
– sequence: 7
  givenname: Zhigang
  surname: Ji
  fullname: Ji, Zhigang
– sequence: 8
  givenname: Hanzhong
  surname: Li
  fullname: Li, Hanzhong
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30514243$$D View this record in MEDLINE/PubMed
BookMark eNp1kl1v0zAYhSM0xLbCD-AGRUJCcJHhz9i-QZomPipNQoJxbTm207pK7WI7E_33uO0KzQTKhS37OSd5T85ldeaDt1X1EoIrCHn7PkHEOW0A5A2FiDTiSXUBCYMNIoCdnezPq8uUVgBAxgF_Vp1jQCFBBF9U7m5p6xyVT_c2Jlsrb-qyy06roTYu5ei6Mbvg69DXmxhSVtnWWnltY-183bmwSdu9LCqzVx0pncN6W6eN1W5tfXpePe3VkOyLh3VW_fj08e7mS3P79fP85vq20S2iuTHU9KxHneC2xYhZwChFWHUIM6g5Mp3hHcOoU0JwLSBpNeNEkJZhzm1nGZ5V84OvCWolN9GtVdzKoJzcH4S4kGo332AlMcQCojToqSLACKEF6EnPIcJYob4tXh8OXpuxW1ujrS9RDRPT6Y13S7kI97JFJWmBi8HbB4MYfo42Zbl2SdthUN6GMUkEKaCYijLirHr9CF2FMfoS1Y7ipPwzzv9SC1UGcL4P5b16ZyqvactbIFpOC3X1D6o8xq6dLiXqXTmfCN5NBIXJ9ldeqDElOf_-bcq-OWGXVg15mcKwb0magq9O0_sT27F9BWAHQJfKpGh7qV1pTvEpn-sGCYHc9Vweei5Lz-Wu51IUJXykPJr_X_Mbd_n9dA
CitedBy_id crossref_primary_10_4143_crt_2019_716
crossref_primary_10_1016_j_urolonc_2021_04_021
crossref_primary_10_1038_s41391_023_00714_x
crossref_primary_10_1038_s41391_020_0205_7
crossref_primary_10_1002_jmri_27138
crossref_primary_10_1007_s00345_023_04729_w
crossref_primary_10_1007_s00259_021_05636_1
crossref_primary_10_4103_iju_iju_36_24
crossref_primary_10_1007_s00345_022_04102_3
crossref_primary_10_1038_s41391_023_00729_4
crossref_primary_10_1186_s40644_022_00516_9
crossref_primary_10_17650_1726_9776_2021_17_2_157_167
crossref_primary_10_1159_000520373
crossref_primary_10_1002_pros_24091
crossref_primary_10_1016_j_euf_2023_01_016
crossref_primary_10_1016_j_xinn_2023_100558
crossref_primary_10_1007_s00345_024_05202_y
Cites_doi 10.1111/bju.13024
10.1016/j.urology.2007.07.072
10.1016/S0360-3016(98)00434-9
10.1007/s11255-016-1484-8
10.1002/pros.22622
10.1016/j.eururo.2014.08.077
10.1016/j.juro.2012.01.066
10.1002/pros.22975
10.1097/COC.0000000000000105
10.1007/s11255-016-1283-2
10.1046/j.1464-410X.2002.02796.x
10.1016/j.eururo.2015.12.015
10.1016/j.eururo.2013.09.045
10.1002/pros.10298
10.1038/nrurol.2013.195
10.1016/j.urolonc.2014.10.006
10.1016/j.urolonc.2008.05.002
10.1016/j.eururo.2014.09.018
10.1016/j.urology.2017.02.027
10.1016/j.eururo.2015.01.030
10.1016/S1470-2045(12)70121-3
10.1016/j.juro.2013.02.021
10.1016/S1470-2045(16)30661-1
10.1002/ijc.2910200506
10.1111/bju.12458
ContentType Journal Article
Copyright COPYRIGHT 2018 BioMed Central Ltd.
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2018
Copyright_xml – notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2018
DBID AAYXX
CITATION
NPM
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12885-018-5124-9
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
PubMed



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 6
ExternalDocumentID oai_doaj_org_article_4d4e04ac0f5a40d99c90f4f81233a2f6
PMC6278093
A568609685
30514243
10_1186_s12885_018_5124_9
Genre Journal Article
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
NPM
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c625t-d5df7f2b98e6327e075523ab2371c82dbd8b732ba998c9146c7849467388ebe73
IEDL.DBID M48
ISSN 1471-2407
IngestDate Wed Aug 27 01:06:06 EDT 2025
Thu Aug 21 14:10:27 EDT 2025
Tue Aug 05 09:45:20 EDT 2025
Fri Jul 25 10:01:32 EDT 2025
Tue Jun 17 21:39:17 EDT 2025
Tue Jun 10 20:18:25 EDT 2025
Fri Jun 27 04:16:35 EDT 2025
Thu May 22 21:01:07 EDT 2025
Thu Apr 03 06:57:33 EDT 2025
Thu Apr 24 22:59:01 EDT 2025
Tue Jul 01 03:06:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Spatial distribution
Radical prostatectomy
Biopsy
Apex
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c625t-d5df7f2b98e6327e075523ab2371c82dbd8b732ba998c9146c7849467388ebe73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-018-5124-9
PMID 30514243
PQID 2158430588
PQPubID 44074
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_4d4e04ac0f5a40d99c90f4f81233a2f6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6278093
proquest_miscellaneous_2150535952
proquest_journals_2158430588
gale_infotracmisc_A568609685
gale_infotracacademiconefile_A568609685
gale_incontextgauss_ISR_A568609685
gale_healthsolutions_A568609685
pubmed_primary_30514243
crossref_citationtrail_10_1186_s12885_018_5124_9
crossref_primary_10_1186_s12885_018_5124_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-12-04
PublicationDateYYYYMMDD 2018-12-04
PublicationDate_xml – month: 12
  year: 2018
  text: 2018-12-04
  day: 04
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2018
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AR Azzouzi (5124_CR11) 2017; 18
DT Chang (5124_CR3) 2013; 10
T Furuno (5124_CR19) 2004; 58
A Sivaraman (5124_CR15) 2016; 69
AV D’Amico (5124_CR8) 1999; 43
IA Donaldson (5124_CR1) 2015; 67
GS Merrick (5124_CR2) 2015; 40
E Baco (5124_CR23) 2015; 67
H Li (5124_CR6) 2007; 70
N Breslow (5124_CR16) 1997; 20
AS Huo (5124_CR21) 2012; 187
M Perera (5124_CR9) 2014; 113
N Bittner (5124_CR17) 2013; 190
J Gordetsky (5124_CR24) 2017; 105
W Yan (5124_CR5) 2009; 27
ED Crawford (5124_CR7) 2013; 73
HU Ahmed (5124_CR12) 2012; 13
SR Bott (5124_CR18) 2002; 89
PB Singh (5124_CR14) 2014; 66
HU Ahmed (5124_CR13) 2015; 68
WJ Ven van de (5124_CR25) 2016; 48
Z Mai (5124_CR4) 2016; 117
M Kido (5124_CR20) 2015; 75
A Richters (5124_CR10) 2015; 33
Q Zhang (5124_CR22) 2017; 49
22498226 - J Urol. 2012 Jun;187(6):2044-9
28238758 - Urology. 2017 Jul;105:18-23
14673955 - Prostate. 2004 Jan 1;58(1):76-81
24061531 - Nat Rev Urol. 2013 Dec;10(12):690-702
25523314 - BJU Int. 2016 Mar;117(3):424-9
23169245 - Prostate. 2013 May;73(7):778-87
23416641 - J Urol. 2013 Aug;190(2):509-14
27068817 - Int Urol Nephrol. 2016 Jul;48(7):1037-45
22512844 - Lancet Oncol. 2012 Jun;13(6):622-32
26778462 - Eur Urol. 2016 Jun;69(6):973-5
28005230 - Int Urol Nephrol. 2017 Mar;49(3):439-448
12010233 - BJU Int. 2002 Jun;89(9):886-9
25456999 - Urol Oncol. 2015 Jan;33(1):16.e9-16.e15
25682339 - Eur Urol. 2015 Dec;68(6):927-36
924691 - Int J Cancer. 1977 Nov 15;20(5):680-8
24053510 - BJU Int. 2014 Mar;113 Suppl 2:29-34
28007457 - Lancet Oncol. 2017 Feb;18(2):181-191
18625566 - Urol Oncol. 2009 Sep-Oct;27(5):520-4
25728717 - Prostate. 2015 Jun 15;75(9):917-22
24207133 - Eur Urol. 2014 Jul;66(1):12-9
18158038 - Urology. 2007 Dec;70(6):1157-61
25281389 - Eur Urol. 2015 Apr;67(4):771-7
25068472 - Am J Clin Oncol. 2017 Feb;40(1):53-59
25240973 - Eur Urol. 2015 Apr;67(4):787-94
10078642 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):587-90
References_xml – volume: 117
  start-page: 424
  issue: 3
  year: 2016
  ident: 5124_CR4
  publication-title: BJU Int
  doi: 10.1111/bju.13024
– volume: 70
  start-page: 1157
  issue: 6
  year: 2007
  ident: 5124_CR6
  publication-title: Urology
  doi: 10.1016/j.urology.2007.07.072
– volume: 43
  start-page: 587
  issue: 3
  year: 1999
  ident: 5124_CR8
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(98)00434-9
– volume: 49
  start-page: 439
  issue: 3
  year: 2017
  ident: 5124_CR22
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-016-1484-8
– volume: 73
  start-page: 778
  issue: 7
  year: 2013
  ident: 5124_CR7
  publication-title: Prostate
  doi: 10.1002/pros.22622
– volume: 67
  start-page: 787
  issue: 4
  year: 2015
  ident: 5124_CR23
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2014.08.077
– volume: 187
  start-page: 2044
  issue: 6
  year: 2012
  ident: 5124_CR21
  publication-title: J Urol
  doi: 10.1016/j.juro.2012.01.066
– volume: 75
  start-page: 917
  issue: 9
  year: 2015
  ident: 5124_CR20
  publication-title: Prostate
  doi: 10.1002/pros.22975
– volume: 40
  start-page: 53
  issue: 1
  year: 2015
  ident: 5124_CR2
  publication-title: Am J Clin Oncol
  doi: 10.1097/COC.0000000000000105
– volume: 48
  start-page: 1037
  issue: 7
  year: 2016
  ident: 5124_CR25
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-016-1283-2
– volume: 89
  start-page: 886
  issue: 9
  year: 2002
  ident: 5124_CR18
  publication-title: BJU Int
  doi: 10.1046/j.1464-410X.2002.02796.x
– volume: 69
  start-page: 973
  issue: 6
  year: 2016
  ident: 5124_CR15
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2015.12.015
– volume: 66
  start-page: 12
  issue: 1
  year: 2014
  ident: 5124_CR14
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2013.09.045
– volume: 58
  start-page: 76
  issue: 1
  year: 2004
  ident: 5124_CR19
  publication-title: Prostate
  doi: 10.1002/pros.10298
– volume: 10
  start-page: 690
  issue: 12
  year: 2013
  ident: 5124_CR3
  publication-title: Nat Rev Urol
  doi: 10.1038/nrurol.2013.195
– volume: 33
  start-page: 16.e9
  issue: 1
  year: 2015
  ident: 5124_CR10
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2014.10.006
– volume: 27
  start-page: 520
  issue: 5
  year: 2009
  ident: 5124_CR5
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2008.05.002
– volume: 67
  start-page: 771
  issue: 4
  year: 2015
  ident: 5124_CR1
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2014.09.018
– volume: 105
  start-page: 18
  year: 2017
  ident: 5124_CR24
  publication-title: Urology
  doi: 10.1016/j.urology.2017.02.027
– volume: 68
  start-page: 927
  issue: 6
  year: 2015
  ident: 5124_CR13
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2015.01.030
– volume: 13
  start-page: 622
  issue: 6
  year: 2012
  ident: 5124_CR12
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70121-3
– volume: 190
  start-page: 509
  issue: 2
  year: 2013
  ident: 5124_CR17
  publication-title: J Urol
  doi: 10.1016/j.juro.2013.02.021
– volume: 18
  start-page: 181
  issue: 2
  year: 2017
  ident: 5124_CR11
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(16)30661-1
– volume: 20
  start-page: 680
  issue: 5
  year: 1997
  ident: 5124_CR16
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910200506
– volume: 113
  start-page: 29
  issue: Suppl 2
  year: 2014
  ident: 5124_CR9
  publication-title: BJU Int
  doi: 10.1111/bju.12458
– reference: 25281389 - Eur Urol. 2015 Apr;67(4):771-7
– reference: 28005230 - Int Urol Nephrol. 2017 Mar;49(3):439-448
– reference: 10078642 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):587-90
– reference: 924691 - Int J Cancer. 1977 Nov 15;20(5):680-8
– reference: 24061531 - Nat Rev Urol. 2013 Dec;10(12):690-702
– reference: 25456999 - Urol Oncol. 2015 Jan;33(1):16.e9-16.e15
– reference: 25728717 - Prostate. 2015 Jun 15;75(9):917-22
– reference: 18625566 - Urol Oncol. 2009 Sep-Oct;27(5):520-4
– reference: 25682339 - Eur Urol. 2015 Dec;68(6):927-36
– reference: 25068472 - Am J Clin Oncol. 2017 Feb;40(1):53-59
– reference: 22498226 - J Urol. 2012 Jun;187(6):2044-9
– reference: 28238758 - Urology. 2017 Jul;105:18-23
– reference: 14673955 - Prostate. 2004 Jan 1;58(1):76-81
– reference: 28007457 - Lancet Oncol. 2017 Feb;18(2):181-191
– reference: 26778462 - Eur Urol. 2016 Jun;69(6):973-5
– reference: 18158038 - Urology. 2007 Dec;70(6):1157-61
– reference: 27068817 - Int Urol Nephrol. 2016 Jul;48(7):1037-45
– reference: 12010233 - BJU Int. 2002 Jun;89(9):886-9
– reference: 24053510 - BJU Int. 2014 Mar;113 Suppl 2:29-34
– reference: 25523314 - BJU Int. 2016 Mar;117(3):424-9
– reference: 22512844 - Lancet Oncol. 2012 Jun;13(6):622-32
– reference: 25240973 - Eur Urol. 2015 Apr;67(4):787-94
– reference: 23416641 - J Urol. 2013 Aug;190(2):509-14
– reference: 24207133 - Eur Urol. 2014 Jul;66(1):12-9
– reference: 23169245 - Prostate. 2013 May;73(7):778-87
SSID ssj0017808
Score 2.3633687
Snippet Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical prostatectomy...
Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using radical...
Abstract Background Prostate biopsy is the most common method for the diagnosis of prostate cancer and the basis for further treatment. Confirmation using...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1205
SubjectTerms Accuracy
Apex
Biopsy
Cancer patients
Cancer surgery
Cancer therapies
Care and treatment
Comparative analysis
Diagnosis
Health aspects
Laparoscopy
Metastasis
Methods
NMR
Nuclear magnetic resonance
Prostate biopsy
Prostate cancer
Prostatectomy
Radical prostatectomy
Spatial distribution
Ultrasonic imaging
Urological surgery
Vertical distribution
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-G311CiCIJTrJmmbPJ7icQrng3pwbyGfuqDtsu0-3H_vTJotWwR98XUzA935yMyQmd8Q8tpXVWxXVpTe8aoU0prSrpQpaxkrFRyORuKg8MXn5vxSfLqqrw5WfWFP2AQPPAnuRHgRKmFcFWsjKq-UU1UUEeIS54bFBLYNMW9fTOX3g1ZWMr9hrmRzMsAtLLFJTZYQ4ESpFlEogfX_eSUfxKRlv-RBADq7Q27nzJGeTl98l9wI3T1y8yK_jd8na9A4HTH0YKdFoKbzNC1bBi1Qj_i4ebUV7SPd4LAHpJnUoda3dN1Ru-43w3Vi25r0ejNTubH_dU1xKBN3AQwPyOXZh2_vz8u8SKF0UN6Mpa99bCOzSoaGszZAmgD1p7GMtysnmbde2pYza6D2cgruTtdKoQQuBJWg5JY_JEdd34XHhMYoRB0MSN4YIZSTkSnDbIi1tSxGVZBqL1jtMso4Lrv4qVO1IRs96UKDLjTqQgPL25llM0Fs_I34HWprJkR07PQD2IzONqP_ZTMFeYG61tOo6ezj-rRuZAM1nawL8ipRIEJGhy04381uGPTHr18WRG8yUezhPzqTJxpAUgiqtaA8XlCCC7vl8d7odL5CBg25mEQ8NikL8nI-Rk5si-tCv0s0iM-jalaQR5ONzpLhiGzPBC9Iu7DeheiWJ936RwIYbxj4j-JP_oesn5JbDP0OO4DEMTkat7vwDPK40T5PLvsb2vlF1g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgiftvz1CiCIJRr07RNnuQUj1M4H9SDfQv5vFvQdm_bfbj_3plstl4R7rWZQJtfZibTzPyGkHeuKEJbGp47WxU5F0bnppQ6r0UopLdYGomFwqffm5Mz_m1RL9IPtyGlVe5sYjTUrrf4j_wQXJNAeiohPq4uc-wahberqYXGbXIHqcswpatdTAFX2YpCpJvMUjSHA9higalqIgc3x3M580WRsv9_w3zNM82zJq-5oeMH5H46P9KjLeAPyS3fPSJ3T9MN-WOyBNzpiA4I8y081Z2jseUyYEEdsuSmBle0D3SFJR9w2KQWsV_TZUfNsl8NV3HaWsc7nEnKjv2fK4qlmdgRYHhCzo6__Pp8kqd2CrmFIGfMXe1CG5iRwjcVaz0cFiAK1YZVbWkFc8YJ01bMaIjArAQLalvBJce2oAKgbqunZK_rO_-c0BA4r73WLGjNubQiMKmZ8aE2hoUgM1LsFlbZxDWOLS9-qxhziEZtsVCAhUIsFEz5ME1ZbYk2bhL-hGhNgsiRHR_063OVVE5xx33BtS1CrXnhpLSyCDzAiaaq4M2bjLxGrNW24HTSdHVUN6KByE7UGXkbJZAno8NEnHO9GQb19eePmdD7JBR6-EarU10DrBRSa80kD2aSoMh2PrzbdCoZkkH92_YZeTMN40xMjut8v4kyyNIja5aRZ9s9Oq1Mhfz2jFcZaWe7d7Z085FueRFpxhsG-iOr_Ztf6wW5x1CjMMOHH5C9cb3xL-GcNppXURn_AudRPVM
  priority: 102
  providerName: ProQuest
Title The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens
URI https://www.ncbi.nlm.nih.gov/pubmed/30514243
https://www.proquest.com/docview/2158430588
https://www.proquest.com/docview/2150535952
https://pubmed.ncbi.nlm.nih.gov/PMC6278093
https://doaj.org/article/4d4e04ac0f5a40d99c90f4f81233a2f6
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_3Ace9iN9WzzWKIAjVbpo2yYPIrdxxCnvI6sLhS0jS5lw423W7C-5_70y2W694-ODLPjQz0M3MZGaamd8Q8rJIEi-GlseFS5OYS2tiO1QmzqRPVOmwNRIbhcfn-dmUf7rILnbIdrxVu4HNjakdzpOaLq7e_Pq5fg8G_y4YvMzfNnDGSixBkzG4Lx6rXbIPjkmgnY75n0sFIRPZXmzeyHZIDlKEA2c87XmpAOb_95F9zWf16ymvOajT2-RWG1nS440q3CE7ZXWXHIzbu_N7ZAYaQZfomrASo6SmKmgYxgxSogXi57ajr2jt6RybQSAMpQ61YkFnFbWzet6sA9vChNudjsot6x9rik2bOCuguU-mpydfP5zF7aCF2EH6s4yLrPDCM6tkmadMlBBGQH5qLEvF0ElW2EJakTJrIDdzCs5WJyRXHAeGSlACkT4ge1VdlY8I9Z7zrDSGeWM4V056pgyzpc-sZd6riCTbjdWuRSHHYRhXOmQjMtcbsWgQi0axaGB53bHMNxAc_yIeobQ6QkTPDg_qxaVujVHzgpcJNy7xmeFJoZRTieceYp00hTfPI_IMZa03rajdGaCPs1zmkPPJLCIvAgUiaFRYonNpVk2jP36Z9IhetUS-hv_oTNvxADuFoFs9yqMeJZi46y9vlU5vLURDrCYRr03KiDzvlpETy-aqsl4FGsTvURmLyMONjnY7s1X1iIie9va2rr9Szb4HAPKcgSmp9PF_cz4hhwztDsuC-BHZWy5W5VMI7pZ2QHbFhRiQ_dHJ-efJIHwiGQQzht_J6Ntvn_lSHg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BqdBLwgvgkMZhAICSla6jiJ_YDQBptatk5obNLejO3YoxIkpWmF-qf4jdwlaViEtLe91ucque_LfRHyOo8inw0ND3MbRyEXRodmKHWYCB9JZ7E1EhuFJ8fp6Ix_Pk_ON8ifdS8MllWudWKtqPPS4jfyHTBNAsdTCfFh9ivErVGYXV2v0GjY4tCtfkPIVr0ffwL6vmHsYP_04yhstwqEFnz9RZgnuc88M1K4NGaZA5sJwZg2LM6GVrDc5MJkMTMaAhErQZHYTHBcRB8LAW-cxfC_N8gmjyGUGZDNvf3jLydd3iITkWhzp0OR7lSg_QUWx4kQDCsPZc_61UsC_jcFl2xhv07zkuE7uEvutB4r3W1Y7B7ZcMV9cnPS5uQfkClwGl2gycMKD0d1kdN6yTNQn-Y4l7ddqUVLT2fYZALuLbXIbXM6LaiZlrNqVV-b6zpr1EHZRflzRbEZFHcQVA_J2bWg-hEZFGXhnhDqPeeJ05p5rTmXVngmNTPOJ8Yw72VAojVilW2nm-OSjR-qjnJEqhpaKKCFQloouPKuuzJrRntcBbyH1OoAcSp3_UM5v1CtkCuecxdxbSOfaB7lUloZee7Bh4pjePI0INtIa9W0uHa6Re0mqUghlhRJQF7VEDiZo8DSnwu9rCo1_nrSA3rbAvkS3tHqtpMCMIXDvHqQWz1IUB22f7xmOtWqrkr9E7SAvOyO8SaW4xWuXNYwOBdIJiwgjxse7TAT40R9xuOAZD3u7aGuf1JMv9eDzVMG8iPjp1c_1ja5NTqdHKmj8fHhM3KboXRhfRHfIoPFfOmeg5e4MC9a0aTk23Vrg78_F3qM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+transverse+and+vertical+distribution+of+prostate+cancer+in+biopsy+and+radical+prostatectomy+specimens&rft.jtitle=BMC+cancer&rft.au=Mai%2C+Zhipeng&rft.au=Zhou%2C+Zhien&rft.au=Yan%2C+Weigang&rft.au=Xiao%2C+Yu&rft.date=2018-12-04&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=18&rft_id=info:doi/10.1186%2Fs12885-018-5124-9&rft_id=info%3Apmid%2F30514243&rft.externalDocID=PMC6278093
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon